HomeATRA • NASDAQ
Atara Biotherapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 32.75M | 670.30% |
Operating expense | 9.44M | -9.13% |
Net income | -12.69M | 79.00% |
Net profit margin | -38.75 | 97.27% |
Earnings per share | -1.19 | 91.50% |
EBITDA | -11.10M | 78.68% |
Effective tax rate | 0.15% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 42.50M | -17.84% |
Total assets | 109.10M | -34.08% |
Total liabilities | 206.38M | -22.04% |
Total equity | -97.28M | — |
Shares outstanding | 5.86M | — |
Price to book | -0.37 | — |
Return on assets | -24.23% | — |
Return on capital | 65.97% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -12.69M | 79.00% |
Cash from operations | -24.47M | 51.45% |
Cash from investing | 3.38M | -66.05% |
Cash from financing | -328.00K | -121.69% |
Net change in cash | -21.42M | 45.00% |
Free cash flow | -19.80M | -365.70% |
Previous close
$6.13
Day range
$5.87 - $6.20
Year range
$5.40 - $20.81
Market cap
35.65M USD
Avg Volume
59.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2012
Headquarters
Website
Employees
153
